Related Experiment Video
Updated: Aug 9, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
The alphaVbeta6 integrin as a novel molecular target for colorectal cancer
1University of Massachusetts Medical School, Department of Cancer Biology, Worcester, MA 01605-2324 USA. Richard.bates@umassmed.edu
Abstract:
Recent advances in the treatment of colorectal cancer have resulted from a shift towards the use of molecular targeting strategies, with the identification of specific antigens critical for the development and progression of these tumors allowing the rational design of new therapeutic agents. The integrin receptor family provides very attractive targets for this 'magic bullet' approach, as they play key roles at all points during the malignant evolution of tumors, influencing growth, progression, angiogenesis and metastasis. One integrin in particular, alphaVbeta6, was recently shown to be upregulated in a model of colorectal tumor progression. Importantly, the consequences of this elevated receptor expression not only impact tumor cell function, but also indicate that alphaVbeta6 is a prognostic variable for colorectal cancer and one that is predictive of patient outcome in early-stage disease. Taken together with its normal expression pattern and known biologic functions, alphaVbeta6 thus emerges as a novel therapeutic candidate.
Insights
AlphaVbeta6 integrin is upregulated in colorectal cancer, impacting tumor progression and patient outcomes. This finding highlights alphaVbeta6 as a potential therapeutic target for novel colorectal cancer treatments.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer (CRC) treatment is advancing with molecular targeting strategies.
- Integrin receptors are key targets due to their roles in tumor growth, angiogenesis, and metastasis.
- AlphaVbeta6 integrin (αVβ6) is upregulated in CRC progression.
Purpose of the Study:
- To investigate the role of alphaVbeta6 integrin in colorectal cancer.
- To evaluate alphaVbeta6 as a prognostic and predictive marker in early-stage CRC.
- To explore alphaVbeta6 as a potential therapeutic target for CRC.
Main Methods:
- Analysis of alphaVbeta6 integrin expression in a colorectal tumor progression model.
- Assessment of the prognostic and predictive value of alphaVbeta6 expression.
- Evaluation of alphaVbeta6's biologic functions and expression patterns.
Main Results:
- AlphaVbeta6 integrin was found to be upregulated in a model of colorectal tumor progression.
- Elevated alphaVbeta6 expression impacts tumor cell function.
- AlphaVbeta6 expression serves as a prognostic variable and predicts patient outcome in early-stage CRC.
Conclusions:
- AlphaVbeta6 integrin plays a significant role in colorectal cancer progression.
- AlphaVbeta6 is a valuable prognostic and predictive biomarker for CRC.
- AlphaVbeta6 represents a novel therapeutic candidate for colorectal cancer treatment.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
06:27A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies
Published on: August 8, 2019
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal